Symetis2022-02-09T19:20:25+00:00

Project Description

Symetis

CEO
Jacques Essinger

Sector
Medical Devices

Location
Ecublens, Switzerland

Investment Stage
Growth

Investment Status
Exit

Year Invested
2016

Endeavour Vision Deal Team
Damien Tappy
Dominik Ellenrieder

Back to all companies

Symetis

Symetis specialises in the development, manufacturing and marketing of next-generation percutaneous heart valve replacement solutions for the treatment of severe cardiac valve conditions.

Symetis was acquired by Boston Scientific in 2017.

Read More
Go to Top